Nicox Ophthalmics, Inc.
Clinical trials sponsored by Nicox Ophthalmics, Inc., explained in plain language.
-
New eye drop challenges standard glaucoma treatment in major trial
Disease control CompletedThis large, completed study compared a new investigational eye drop called NCX 470 to a standard medication (latanoprost) for treating open-angle glaucoma and ocular hypertension. The main goal was to see if the new drop was safe and effective at lowering high pressure inside the…
Phase: PHASE3 • Sponsor: Nicox Ophthalmics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New eye drop tested to control glaucoma pressure
Disease control CompletedThis study tested how a new eye drop called NCX 470 affects fluid pressure inside the eye in people with or at risk for open-angle glaucoma. Researchers compared the eye drop to a placebo (inactive) solution in 18 participants over about 8 days. The goal was to understand if and …
Phase: PHASE2, PHASE3 • Sponsor: Nicox Ophthalmics, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC